Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Substance in cancer medicine could prevent heart attacks

23.11.2011
A substance in medicines for cancer and epilepsy could also prevent heart attacks, according to researchers at the Sahlgrenska Academy at the University of Gothenburg, Sweden,, who have been using it to stimulate the body’s own defence system against blood clots.

Heart attacks are normally caused by the formation of a blood clot in one of the blood vessels that supply the heart with oxygen and nutrients. The clot reduces the supply of oxygen, which can very quickly result in irreparable damage to the heart.

The body´s own protection

The body has a natural defence system to prevent blood clots – the fibrinolytic system – which ““sprays““ a special enzyme over the clots to break them down before they manage to obstruct the vessel. However, in order to function properly, this system needs sufficient quantities of the enzyme to be stored in the vessel wall. Unfortunately these stores are often depleted because of hereditary and lifestyle factors, such as high blood pressure, smoking and overweight, which probably increases the risk of a heart attack.

New ways of preventing heart attack

Researchers at the University of Gothenburg’s Sahlgrenska Academy have been looking at a way to stimulate the clot-dissolving system. The results are promising and open the door to new ways of preventing heart attacks.

“We’re trying to find a medicine that boosts the stores of the enzyme as this probably would help the body to prevent heart attacks,” says Pia Larsson at the Sahlgrenska Academy, who is basing her thesis on the study.

Stimulates enzyme production

Previously tested substances have proved unsuitable, mainly because of their unwanted side-effects. In the present study the Sahlgrenska researchers used HDAC inhibitors, substances new to this particular context, and managed to stimulate production of the relevant enzyme.

“We found that treatment with HDAC inhibitors dramatically increased production of the clot-dissolving enzyme, and that this occurred at far lower concentrations than expected,” says Larsson.

Side-effects well known

The advantage of HDAC inhibitors is that they are already used in medication for illnesses such as epilepsy and cancer, which means that their pharmacological properties and side-effects are known.

Larsson says that more research is needed before a drug to prevent heart attacks can be launched.

“Our trials have been carried out on cultured cells from the vessel wall and we can’t guarantee that the cells, when present in the body, will behave in exactly the same way. The results must therefore be tested on people before we can draw any firm conclusions.”

Furhter investigation

The Sahlgrenska researchers are therefore preparing the first in a series of studies on human subjects to further investigate the effect of HDAC inhibitors on the clot-dissolving enzyme.

The thesis, “Regulation of Vascular Endothelial t-PA Expression in Inflammation – Potential Target for Pharmacological Modulation” was defended on 18 November.

For more information, please contact: Pia Larsson
Telephone: +46 (0)736 240 394
E-mail: pia.larsson@gu.se

Helena Aaberg | idw
Further information:
http://www.gu.se

More articles from Life Sciences:

nachricht 'Lipid asymmetry' plays key role in activating immune cells
20.02.2018 | Biophysical Society

nachricht New printing technique uses cells and molecules to recreate biological structures
20.02.2018 | Queen Mary University of London

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: In best circles: First integrated circuit from self-assembled polymer

For the first time, a team of researchers at the Max-Planck Institute (MPI) for Polymer Research in Mainz, Germany, has succeeded in making an integrated circuit (IC) from just a monolayer of a semiconducting polymer via a bottom-up, self-assembly approach.

In the self-assembly process, the semiconducting polymer arranges itself into an ordered monolayer in a transistor. The transistors are binary switches used...

Im Focus: Demonstration of a single molecule piezoelectric effect

Breakthrough provides a new concept of the design of molecular motors, sensors and electricity generators at nanoscale

Researchers from the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), Institute of Physics of the CAS (IP CAS) and Palacký University...

Im Focus: Hybrid optics bring color imaging using ultrathin metalenses into focus

For photographers and scientists, lenses are lifesavers. They reflect and refract light, making possible the imaging systems that drive discovery through the microscope and preserve history through cameras.

But today's glass-based lenses are bulky and resist miniaturization. Next-generation technologies, such as ultrathin cameras or tiny microscopes, require...

Im Focus: Stem cell divisions in the adult brain seen for the first time

Scientists from the University of Zurich have succeeded for the first time in tracking individual stem cells and their neuronal progeny over months within the intact adult brain. This study sheds light on how new neurons are produced throughout life.

The generation of new nerve cells was once thought to taper off at the end of embryonic development. However, recent research has shown that the adult brain...

Im Focus: Interference as a new method for cooling quantum devices

Theoretical physicists propose to use negative interference to control heat flow in quantum devices. Study published in Physical Review Letters

Quantum computer parts are sensitive and need to be cooled to very low temperatures. Their tiny size makes them particularly susceptible to a temperature...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

2nd International Conference on High Temperature Shape Memory Alloys (HTSMAs)

15.02.2018 | Event News

Aachen DC Grid Summit 2018

13.02.2018 | Event News

How Global Climate Policy Can Learn from the Energy Transition

12.02.2018 | Event News

 
Latest News

'Lipid asymmetry' plays key role in activating immune cells

20.02.2018 | Life Sciences

MRI technique differentiates benign breast lesions from malignancies

20.02.2018 | Medical Engineering

Major discovery in controlling quantum states of single atoms

20.02.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>